Professional paper - Review paper
Bevacizumab and corneal pathology

Bilen Babić, Marijana; Merlak, Maja (2017)
Cite this document...

Bilen Babić, M. & Merlak, M. (2017). Bevacizumab i patologija rožnice. Medicina Fluminensis : Medicina Fluminensis, 53. (2), 204-209. doi: 10.21860/medflum2017_179759

Bilen Babić, Marijana and Maja Merlak. "Bevacizumab i patologija rožnice." Medicina Fluminensis : Medicina Fluminensis, vol. 53, no. 2, 2017, pp. 204-209. https://doi.org/10.21860/medflum2017_179759

Bilen Babić, Marijana and Maja Merlak. "Bevacizumab i patologija rožnice." Medicina Fluminensis : Medicina Fluminensis 53, no. 2 (2017): 204-209. https://doi.org/10.21860/medflum2017_179759

Bilen Babić, M. and Merlak, M. (2017) 'Bevacizumab i patologija rožnice', Medicina Fluminensis : Medicina Fluminensis, 53(2), pp. 204-209. doi: 10.21860/medflum2017_179759

Bilen Babić M, Merlak M. Bevacizumab i patologija rožnice. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2017 June 01 [cited 2019 March 19];53(2):204-209. doi: 10.21860/medflum2017_179759

M. Bilen Babić and M. Merlak, "Bevacizumab i patologija rožnice", Medicina Fluminensis : Medicina Fluminensis, vol. 53, no. 2, pp. 204-209, June 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:750658. [Accessed: 19 March 2019]